|  SummaryA challenge study was conducted to determine the efficacy of   vaccination against bluetongue (BT) virus (BTV) serotype 2 in protecting cattle   against infection. A group of 30 cows, vaccinated seven months previously with   monovalent BTV-2 modified-live vaccine produced by Onderstepoort Biological   Products in South Africa, were challenged subcutaneously with 2 × 10   5.8 TCID 50 /ml of BTV-2 field isolate. All cattle originated from the same   population in the Sardinian province of Oristano. Eight unvaccinated calves from   a BTV-free herd also participated in this study; four were inoculated with BTV-2   and used as positive controls whilst the remaining four were used as negative   controls to confirm that no BTV was circulating locally. Blood samples were   taken from all animals three times a week for two months. Serum samples were   tested for antibody against BTV using the competitive enzyme-linked   immunosorbent assay (c-ELISA) and the virus neutralisation (VN) test. Virus   isolation was attempted on the blood samples by intravenous egg inoculation   followed by two blind passages in Vero cells. Virus titres following challenge   were determined also. Of the 30 cows vaccinated, 29 were positive in the c-ELISA   and demonstrated neutralising antibodies. At the time of challenge, 11 cows had   no virus neutralising antibody while the remainder had low titres ranging from   1:10 (11 cows) to 1:20 (6 cows); two cows showed titres of 1:40 and 1:80,   respectively. None of the cows showed signs of disease after challenge and no   BTV was isolated from the blood of the 29 cows that had developed antibodies   after vaccination. Commencing on day 9 post challenge, BTV-2 was isolated from   the blood of the single cow that had not seroconverted following vaccination and   from the blood of the unvaccinated controls. Viraemia lasted until day 21 post   challenge. Neither BTV nor antibody was detected in the blood samples taken from   the negative control group. These observations indicate that the monovalent   BTV-2 modified-live vaccine protects most animals when challenged with field   virus seven months post vaccination.
 KeywordsBluetongue,  Cattle, Challenge, Competitive enzyme-linked immunosorbent assay, Vaccine,  Viraemia, Virus, Virus neutralisation.
 |